Mean cost of the procedure was $10,183±$1,082 in 30 pts studied for cost analysis. 22 outpts vs. 8 overnight pts : Total charges: $9,873 vs. $11,034 (p<0.01) Professional fees: $6,163 vs. $6,286 (p=NS) Hospital charges: $3,710 vs. $4,748 (p<0.01) 2 pts w/ complications: femoral artery pseudoaneurysm notes 3-4 wk after procedure, one in outpt, one after 13 h overnight stay. Kertes PJ CE of RFA compared 26 AVNRT (n=16) Mean cost of RFA $4067, c/w N/A RFA more cost-effective than AADs. 1993 to AADs in Australia WPW (n=10) AAD of $700/ y (389) Limited to Australian population, but NOTE: these are likely results consistent w/ other series. Australian dollars, although authors do not specify Used pt data in constructing not simulation. Extrapolating over 20 y and allowing for an annual 5% inflation factor, RFA becomes cost saving in 5.5 y Over 20 y, AAD estimated at times more expensive than RF Perspective: pt and societal Outcomes: cost analysis w/ “cost-saving” criterion used to define effectiveness, on the assumption that RFA is at least as effective as AADs in control of PSVT; authors used annual charges Ikeda T Prospective cohort, CE 20 Symptomatic PSVT, on Mean total charge for ablation N/A Small study, limited to Japan, but 1994 evaluation of CE of AADs, all w/ successful RFA 982,806 yen and 5.7 times the suggests RFA effective and reduces (390) RFA for PSVT outpt charges in the previous y medical costs. AVNRT (n=5) WPW (n=15) Mean total life-expectancy Utilizes hospital charges, and not a
Mean cost of the procedure was $10,183±$1,082 in 30 pts studied for cost analysis. 22 outpts vs. 8 overnight pts : Total charges: $9,873 vs. $11,034 (p<0.01) Professional fees: $6,163 vs. $6,286 (p=NS) Hospital charges: $3,710 vs. $4,748 (p<0.01) 2 pts w/ complications: femoral artery pseudoaneurysm notes 3-4 wk after procedure, one in outpt, one after 13 h overnight stay. Kertes PJ 1993 (389) CE of RFA compared to AADs in Australia 26 AVNRT (n=16) WPW (n=10) Mean cost of RFA $4067, c/w AAD of $700/ y NOTE: these are likely Australian dollars, although authors do not specify Extrapolating over 20 y and allowing for an annual 5% inflation factor, RFA becomes cost saving in 5.5 y Over 20 y, AAD estimated at times more expensive than RF Perspective: pt and societal Outcomes: cost analysis w/ “cost-saving” criterion used to define effectiveness, on the assumption that RFA is at least as effective as AADs in control of PSVT; authors used annual charges N/A RFA more cost-effective than AADs. Limited to Australian population, but results consistent w/ other series. Used pt data in constructing not simulation. Ikeda T 1994 (390) Prospective cohort, CE evaluation of CE of RFA for PSVT 20 Symptomatic PSVT, on AADs, all w/ successful RFA AVNRT (n=5) WPW (n=15) Mean total charge for ablation 982,806 yen and 5.7 times the outpt charges in the previous y Mean total life-expectancy N/A Small study, limited to Japan, but suggests RFA effective and reduces medical costs. Utilizes hospital charges, and not a
2015_SVT_Evidence_Tables_Data_Supplement.docx